Antineoplastic agents. 565. Synthesis of combretastatin D-2 phosphate and dihydro-combretastatin D-2

George Pettit; Peter D. Quistorf; Jeremy A. Fry; Delbert L. Herald; Ernest Hamel; Jean Chapuis

doi:10.1021/np800635h

Antineoplastic agents. 565. Synthesis of combretastatin D-2 phosphate and dihydro-combretastatin D-2

George Pettit, Peter D. Quistorf, Jeremy A. Fry, Delbert L. Herald, Ernest Hamel, Jean Chapuis

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Abstract

A modified synthetic route to combretastatin D-2 (5) was devised in order to further evaluate its biological activity, for its conversion to phosphate prodrugs (25-28), and as a route to obtaining dihydro-combretastatin D-2 (42). A parallel first total synthesis of dihydro-combretastatin D-2 was completed, proceeding from a saturated 3-phenylpropionic ester intermediate via the Ullmann biaryl ether reaction (39-41). In contrast to the cancer cell growth inhibitory activity exhibited by combretastatin D-2, relatively minor structural modifications (41, 42) caused elimination of those properties.

Original language	English (US)
Pages (from-to)	876-883
Number of pages	8
Journal	Journal of Natural Products
Volume	72
Issue number	5
DOIs	https://doi.org/10.1021/np800635h
State	Published - May 22 2009

ASJC Scopus subject areas

Analytical Chemistry
Molecular Medicine
Pharmacology
Pharmaceutical Science
Drug Discovery
Complementary and alternative medicine
Organic Chemistry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1021/np800635h

Cite this

@article{840d7ea2e16346e0aabe6d43425c56c8,

title = "Antineoplastic agents. 565. Synthesis of combretastatin D-2 phosphate and dihydro-combretastatin D-2",

abstract = "A modified synthetic route to combretastatin D-2 (5) was devised in order to further evaluate its biological activity, for its conversion to phosphate prodrugs (25-28), and as a route to obtaining dihydro-combretastatin D-2 (42). A parallel first total synthesis of dihydro-combretastatin D-2 was completed, proceeding from a saturated 3-phenylpropionic ester intermediate via the Ullmann biaryl ether reaction (39-41). In contrast to the cancer cell growth inhibitory activity exhibited by combretastatin D-2, relatively minor structural modifications (41, 42) caused elimination of those properties.",

author = "George Pettit and Quistorf, {Peter D.} and Fry, {Jeremy A.} and Herald, {Delbert L.} and Ernest Hamel and Jean Chapuis",

year = "2009",

month = may,

day = "22",

doi = "10.1021/np800635h",

language = "English (US)",

volume = "72",

pages = "876--883",

journal = "Journal of Natural Products",

issn = "0163-3864",

publisher = "American Chemical Society",

number = "5",

}

TY - JOUR

T1 - Antineoplastic agents. 565. Synthesis of combretastatin D-2 phosphate and dihydro-combretastatin D-2

AU - Pettit, George

AU - Quistorf, Peter D.

AU - Fry, Jeremy A.

AU - Herald, Delbert L.

AU - Hamel, Ernest

AU - Chapuis, Jean

PY - 2009/5/22

Y1 - 2009/5/22

N2 - A modified synthetic route to combretastatin D-2 (5) was devised in order to further evaluate its biological activity, for its conversion to phosphate prodrugs (25-28), and as a route to obtaining dihydro-combretastatin D-2 (42). A parallel first total synthesis of dihydro-combretastatin D-2 was completed, proceeding from a saturated 3-phenylpropionic ester intermediate via the Ullmann biaryl ether reaction (39-41). In contrast to the cancer cell growth inhibitory activity exhibited by combretastatin D-2, relatively minor structural modifications (41, 42) caused elimination of those properties.

AB - A modified synthetic route to combretastatin D-2 (5) was devised in order to further evaluate its biological activity, for its conversion to phosphate prodrugs (25-28), and as a route to obtaining dihydro-combretastatin D-2 (42). A parallel first total synthesis of dihydro-combretastatin D-2 was completed, proceeding from a saturated 3-phenylpropionic ester intermediate via the Ullmann biaryl ether reaction (39-41). In contrast to the cancer cell growth inhibitory activity exhibited by combretastatin D-2, relatively minor structural modifications (41, 42) caused elimination of those properties.

UR - http://www.scopus.com/inward/record.url?scp=66449124775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66449124775&partnerID=8YFLogxK

U2 - 10.1021/np800635h

DO - 10.1021/np800635h

M3 - Article

C2 - 20161135

AN - SCOPUS:66449124775

VL - 72

SP - 876

EP - 883

JO - Journal of Natural Products

JF - Journal of Natural Products

SN - 0163-3864

IS - 5

ER -

Antineoplastic agents. 565. Synthesis of combretastatin D-2 phosphate and dihydro-combretastatin D-2

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this